Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             191 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 45A A clinical events system with committee review for a large clinical trials network Green, Lisa A.
1995
16 3S1 p. 58S-59S
nvt p.
artikel
2 01A A comparison of the performance of several phase I designs Odom-Maryon, Tamara
1995
16 3S1 p. 33S-
1 p.
artikel
3 34A Adjusting estimates of a laboratory parameter effect in a neonatal study based on center differences in a multi-center Boardman, Chris
1995
16 3S1 p. 52S-
1 p.
artikel
4 57A A graphical assessment of the potential impact of losses to followup on the validity of study results Matts, John P.
1995
16 3S1 p. 65S-66S
nvt p.
artikel
5 62A A meta-analysis of clinical trials involving both continuous and binary outcomes Whitehead, Anne
1995
16 3S1 p. 68S-
1 p.
artikel
6 30A Analysis on clinical signs and symptoms of antimicrobial trials Yang, Joanna
1995
16 3S1 p. 50S-
1 p.
artikel
7 68A Analyzing multiple endpoints from multiple time periods with multiple groups: The PEPI cohort Legault, Claudine
1995
16 3S1 p. 71S-
1 p.
artikel
8 51A Applying the “real-time meta-analysis system” to randomized control trials of congestive heart failure Cappelleri, Joseph C.
1995
16 3S1 p. 62S-
1 p.
artikel
9 54A A randomized trial with surgery as the manoeuvre and endpoint Kestle, J.
1995
16 3S1 p. 64S-
1 p.
artikel
10 27A Are clinical trial participants comparable to non-participants? Weijer, Charles
1995
16 3S1 p. 48S-
1 p.
artikel
11 21A Are we promoting a true informed consent for participation in randomized clinical trials? DeLuca, Sue A.
1995
16 3S1 p. 44S-
1 p.
artikel
12 09A Assessing medication adherence in the African American study of kidney disease and hypertension (AASK) pilot study Lee, Jeannette
1995
16 3S1 p. 37S-
1 p.
artikel
13 36A Assessing neurodevelopment in pediatric HIV patients Rutkiewicz, Victoria
1995
16 3S1 p. 53S-
1 p.
artikel
14 46A A survey of data entry methods: Substituting data for “religion” Singer, Stephen W.
1995
16 3S1 p. 59S-
1 p.
artikel
15 38A Benefit-risk ratios in the assessment of the clinical evidence of a new therapy Willan, Andrew R.
1995
16 3S1 p. 54S-
1 p.
artikel
16 48A Benefits of a centralized clinical trials data management system Matza, Martha J.
1995
16 3S1 p. 60S-
1 p.
artikel
17 19A Challenge of minority recruitment in clinical trials: Experience of the African American study of kidney disease and hypertension (AASK) pilot study Whelton, Paul
1995
16 3S1 p. 43S-
1 p.
artikel
18 24A Challenges of a large simple trial: The Zerit® parallel track Brunell, Robert
1995
16 3S1 p. 46S-
1 p.
artikel
19 65A Chaos theory and prognosis: Selection of patients with arrhythmias and an increased risk of sudden cardiac death Ulm, K.
1995
16 3S1 p. 70S-
1 p.
artikel
20 17A Clinical trial participant satisfaction: Survey of 4281 participants in the systolic hypertension in the elderly program Schron, Eleanor B.
1995
16 3S1 p. 41S-42S
nvt p.
artikel
21 28A Comparison of median survival times with adjustment for covariates Karrison, Theodore
1995
16 3S1 p. 48S-49S
nvt p.
artikel
22 22A Comparison of methods for health economic measurements in clinical trials Walker, Valery
1995
16 3S1 p. 45S-
1 p.
artikel
23 56A Comparison of time-to-event and slope-based analyses in nephrology clinical trials Greene, Tom
1995
16 3S1 p. 65S-
1 p.
artikel
24 02A Considerations in designing pediatric drug trials Simpson, Pippa
1995
16 3S1 p. 33S-
1 p.
artikel
25 26A Coronary revascularization practice in the 1990s is it different at academic centers? Rosen, Allan D.
1995
16 3S1 p. 47S-48S
nvt p.
artikel
26 23A Cost-effectiveness analysis in the V.A. Cooperative Study of transurethral resection of the prostate vs. watchful waiting in benign prostatic hyperplasia Henderson, William
1995
16 3S1 p. 45S-46S
nvt p.
artikel
27 50A Critical events management Viséle, Nathalie
1995
16 3S1 p. 61S-62S
nvt p.
artikel
28 35A Defining and analyzing asthma exacerbation Zhang, Ji
1995
16 3S1 p. 52S-
1 p.
artikel
29 67A Designed extension of studies based on conditional power Proschan, Michael A.
1995
16 3S1 p. 71S-
1 p.
artikel
30 43A Did blinding work in a trial of lipid-lowering and low-dose anticoagulant agents? Margitic, Susan
1995
16 3S1 p. 57S-
1 p.
artikel
31 52A Effectiveness of a placebo run-in period in increasing the power of a chemoprevention trial, CARET Thornquist, Mark
1995
16 3S1 p. 63S-
1 p.
artikel
32 11A Electronic document archival for a data coordinating center Wong, Kenneth
1995
16 3S1 p. 38S-
1 p.
artikel
33 32A Estimating rate of change in lumbar spine bone mineral density in clinical trials for treatments of osteoporosis Yuan, Weiying
1995
16 3S1 p. 51S-
1 p.
artikel
34 06A From clinical trial to bedside: Enhancing patient care through the use of continuous quality improvement techniques Ackman, Margaret L.
1995
16 3S1 p. 35S-
1 p.
artikel
35 07A How do clinic coordinators spend their time? Church, Renee Y.
1995
16 3S1 p. 36S-
1 p.
artikel
36 33A How we used graphics in the Lung Health Study Connett, John E.
1995
16 3S1 p. 51S-
1 p.
artikel
37 41A Impact of trial results on clinical practice one year following the systolic hypertension in the elderly program Herzog, Holly C.
1995
16 3S1 p. 56S-
1 p.
artikel
38 39A Incorporating toxicity grade information in the continual reassessment method for phase I cancer clinical trials de Moor, Carl A.
1995
16 3S1 p. 54S-55S
nvt p.
artikel
39 13A Information-based monitoring and design of time to event studies Scharfstein, Daniel O.
1995
16 3S1 p. 39S-
1 p.
artikel
40 12A Interactive database management (IDM) Othman, R.O.
1995
16 3S1 p. 38S-39S
nvt p.
artikel
41 64A Investigating the stability of patient classification into risk groups: An example in Crohn's disease Sahmoud, Tarek
1995
16 3S1 p. 69S-
1 p.
artikel
42 04A Legislative oversight of clinical trials Kane, Christopher D.
1995
16 3S1 p. 34S-
1 p.
artikel
43 58A Measuring the impact of the control rate in meta-analysis of clinical trials Schmid, Christopher H.
1995
16 3S1 p. 66S-
1 p.
artikel
44 60A Ovarian ablation — Why the Early Breast Cancer Trialists' Collaborative Group's (EBCTCG) individual patient data meta-analysis was needed Clarke, Mike
1995
16 3S1 p. 67S-68S
nvt p.
artikel
45 15A Paternal cell immunization for recurrent miscarriage: A comparison of meta-analyses with and without individual patient data Jeng, Gary T.
1995
16 3S1 p. 40S-
1 p.
artikel
46 69A Performance of the National Death Index and probabilistic decision rules for reducing the number of false matches Kosinski, Andrzej S.
1995
16 3S1 p. 72S-
1 p.
artikel
47 14A Publication and reporting of phase I clinical trials Winget, Marcy
1995
16 3S1 p. 40S-
1 p.
artikel
48 37A Quality of life measurement in an HIV-clinical trial Messina, Marianne
1995
16 3S1 p. 53S-54S
nvt p.
artikel
49 66A Randomized and non-randomized patients in clinical trials: Experiences with comprehensive cohort studies Sauerbrei, W.
1995
16 3S1 p. 70S-71S
nvt p.
artikel
50 53A Randomize the first patient? Benefits and risks of adding a new treatment-arm to a longterm clinical trial Hasford, Joerg
1995
16 3S1 p. 63S-64S
nvt p.
artikel
51 18A Reasons for joining and barriers to participation in the African-American study of kidney disease and hypertension (AASK) pilot study Kusek, John
1995
16 3S1 p. 42S-
1 p.
artikel
52 55A Role for clinical databases and risk adjustment in clinical trial analytic plans Knaus, W.A.
1995
16 3S1 p. 64S-65S
nvt p.
artikel
53 49A Standard interface to a clinical trials data management system Welch, Susan Rea
1995
16 3S1 p. 61S-
1 p.
artikel
54 08A TermPROM coordinator survey Hewson, Sheila
1995
16 3S1 p. 36S-
1 p.
artikel
55 25A The antihypertensive and lipid lowering treatment to prevent heart attack trial: Design features Davis, Barry R.
1995
16 3S1 p. 47S-
1 p.
artikel
56 42A The effect of long-term treatment with oral anticoagulants on mortality and cardiovascular morbidity after myocardial infarction Azar, Aida J.
1995
16 3S1 p. 56S-57S
nvt p.
artikel
57 59A The fallacy of the analysis of treatment effect according to the control group rates in systematic reviews Torri, V.
1995
16 3S1 p. 67S-
1 p.
artikel
58 40A The identification of predictive factors of missing follow-up in GISSI-3 trial Bonfanti, E.
1995
16 3S1 p. 55S-
1 p.
artikel
59 20A The impact of simultaneous participation on two large multicentre, multinational clinical trials Fabri, Jackie
1995
16 3S1 p. 43S-44S
nvt p.
artikel
60 05A The international register of RCTS of health care Dickersin, Kay
1995
16 3S1 p. 35S-
1 p.
artikel
61 16A The use of incentives to increase participation in a chemoprevention trial Bowen, Deborah
1995
16 3S1 p. 41S-
1 p.
artikel
62 29A The use of Poisson regression methods in clinical trials Thompson, Desmond
1995
16 3S1 p. 49S-
1 p.
artikel
63 31A Tracking in random regression mixed models for longitudinal data: Graphical examination and comparison of BLUP and OLS procedures Helms, Ronald W.
1995
16 3S1 p. 50S-
1 p.
artikel
64 44A Treatment effects monitoring practices as viewed through the published literature Kiri, Antariksha
1995
16 3S1 p. 58S-
1 p.
artikel
65 10A Use of the internet in coordinating information from clinical centers and a central laboratory in the Mortality and Morbidity in Hemodialysis (MMHD) study Drabik, M.
1995
16 3S1 p. 37S-38S
nvt p.
artikel
66 61A User requirements for the meta-analysis of individual patient data Sylvester, Richard
1995
16 3S1 p. 68S-
1 p.
artikel
67 Author index 1995
16 3S1 p. 142S-158S
nvt p.
artikel
68 63A Utilizing sequential monitoring boundaries for cumulative meta-analysis Pogue, Janice
1995
16 3S1 p. 69S-
1 p.
artikel
69 47A Validation of computer systems for clinical trials — Experiences with a practical implementation Brandmaier, Roland
1995
16 3S1 p. 60S-
1 p.
artikel
70 03A Visit windows and drug supplies Guidarelli, Loretta A.
1995
16 3S1 p. 34S-
1 p.
artikel
71 Calendar of program 1995
16 3S1 p. 3S-31S
nvt p.
artikel
72 Letter from the President 1995
16 3S1 p. 1S-
1 p.
artikel
73 P31 A bayesian belief network for exploratory longitudinal analysis Clarke, Ellis
1995
16 3S1 p. 89S-90S
nvt p.
artikel
74 P116 A comparison of APACHE II (Acute Physiology And Chronic Health Evaluation score) and MODS (Multiple Organ Dysfunction Score) in predicting ICU mortality Griffith, Lauren
1995
16 3S1 p. 138S-
1 p.
artikel
75 P06 A comparison of key data entry versus FAX data entry, accuracy and time Lancaster, Scott
1995
16 3S1 p. 75S-76S
nvt p.
artikel
76 P55 A comparison of medical abstraction and physician review of hospital records in the lung health study Lee, Wondra Wong
1995
16 3S1 p. 104S-
1 p.
artikel
77 P37 A comparison of methods used to summarize responses on the Functional Status Questionnaire (FSQ) unscaled responses vs scaled scores Randall, A.M.Y.
1995
16 3S1 p. 93S-
1 p.
artikel
78 P11 A complex data editing system utilizing Structured Query Language (SQL) Jones, Martha F.
1995
16 3S1 p. 78S-79S
nvt p.
artikel
79 P09 A data collection system designed to facilitate participation in multiple concurrent clinical trials Wentworth, Deborah
1995
16 3S1 p. 77S-
1 p.
artikel
80 P10 A data management tool for tracking clinical endpoint reviews Myers, Marcella
1995
16 3S1 p. 78S-
1 p.
artikel
81 P25 Age, sex, and race in ophthalmology randomized clinical trials Crawley, Barbara
1995
16 3S1 p. 86S-
1 p.
artikel
82 P110 Analyses of repeated measurements data from two treatment groups Huang, David C.
1995
16 3S1 p. 135S-
1 p.
artikel
83 P16 An automated editing process for research databases Moke, Pamela S.
1995
16 3S1 p. 81S-
1 p.
artikel
84 P70 An electronic interface for reporting and tracking significant clinical events Pelusio, Rita M.
1995
16 3S1 p. 112S-113S
nvt p.
artikel
85 P29 An evaluation of methods for sensitivity and specificity when the observations are correlated Ahn, Chul
1995
16 3S1 p. 88S-89S
nvt p.
artikel
86 P92 Angiographic eligibility assessment in the bypass angioplasty revascularization investigation Wisniewski, Stephen R.
1995
16 3S1 p. 124S-125S
nvt p.
artikel
87 P19 An integrated system for meta-analyses of individual patient data: Data dictionary and database structure Bijnens, Luc
1995
16 3S1 p. 82S-83S
nvt p.
artikel
88 P94 A one page daily calendar as an aid in tracking variables in clinical trials Wilkins, Annette
1995
16 3S1 p. 125S-126S
nvt p.
artikel
89 P23 Appending a cost-effectiveness analysis to a randomized trial of laparoscopic surgery Gray, Darryl
1995
16 3S1 p. 85S-
1 p.
artikel
90 P34 Applying cause-specific failure endpoint analysis strategies Panzarella, Tony
1995
16 3S1 p. 91S-
1 p.
artikel
91 P46 A protocol to minimize bias and regression to the mean in measurement of intraocular pressure Gordon, Mae O.
1995
16 3S1 p. 98S-99S
nvt p.
artikel
92 P48 A quality control study of radionuclide ventriculogram readings of left ventricular ejection fraction without using a core lab Bost, James E.
1995
16 3S1 p. 100S-
1 p.
artikel
93 P115 A review of recent statistical methods for the analysis of the 2x2 crossover design in clinical trials Stepanavage, Michael
1995
16 3S1 p. 137S-
1 p.
artikel
94 P76 A SAS macro to perform the randomization test alternative to the dependent samples t-test Foster, Gary A.
1995
16 3S1 p. 115S-116S
nvt p.
artikel
95 P83 A sequential design to assess the efficacy of dry polymer gel pads during mayor surgery McElvenny, Damien
1995
16 3S1 p. 119S-120S
nvt p.
artikel
96 P81 A trial evaluating the home treatment of patients with acute proximal deep vein thrombosis (DVT) Haley, Susan
1995
16 3S1 p. 118S-
1 p.
artikel
97 P106 A useful management technique for monitoring the progress of large multi-national clinical trials Karnash, Sharon
1995
16 3S1 p. 133S-
1 p.
artikel
98 P64 Automated generation of program code and documentation for database error checking Connorton, Joseph
1995
16 3S1 p. 109S-
1 p.
artikel
99 P72 A windows interface to a relational database for data management Jones, Martha F.
1995
16 3S1 p. 113S-114S
nvt p.
artikel
100 P88 Barriers encountered in the conduct of clinical studies: A case in point. Perioperatively discontinuation of MTX Alarcón, Graciela S.
1995
16 3S1 p. 122S-123S
nvt p.
artikel
101 P03 Being prepared: A case study Remaley, Nancy
1995
16 3S1 p. 74S-
1 p.
artikel
102 P05 Beyond intra-form and inter-form editing: Inter-study editing and quality assurance Eng, Heather
1995
16 3S1 p. 75S-
1 p.
artikel
103 P90 Biologic variability in the evaluation of osteoporosis Simpson, Pippa
1995
16 3S1 p. 123S-
1 p.
artikel
104 P96 Biostatistical/clinical issues in global drug development Herson, Jay
1995
16 3S1 p. 127S-
1 p.
artikel
105 P42 Blinding and exclusions after randomization in controlled trials Schulz, Kenneth F.
1995
16 3S1 p. 95S-96S
nvt p.
artikel
106 P12 Blueprint for a data collection tool Hewson, Sheila
1995
16 3S1 p. 79S-
1 p.
artikel
107 P108 Central measurement of comorbidity and local measurement of functional status and quality of life in the mortality and morbidity in hemodialysis (MMHD) Pilot Study Gassman, Jennifer
1995
16 3S1 p. 134S-
1 p.
artikel
108 P73 Clinical site staff turnover: Effective training approaches in a multi-center clinical trial Crow, Sharon
1995
16 3S1 p. 114S-
1 p.
artikel
109 P61 Closeout issues in a permanently implantable investigational device study Morgan, Nancy
1995
16 3S1 p. 108S-
1 p.
artikel
110 P63 Communication procedures for on-going clinical trials Nowakowski, Deborah J.
1995
16 3S1 p. 109S-
1 p.
artikel
111 P107 Comparison of inevaluability rates between community and comprehensive center investigators Winn, Rodger J.
1995
16 3S1 p. 133S-134S
nvt p.
artikel
112 P100 Comparison of tablet measures by calibrated cylinder versus tablet count in the DIG study Fye, Carol L.
1995
16 3S1 p. 129S-
1 p.
artikel
113 P08 Computer aided telephone screening and recruitment via in-house developed PC FoxPro application Little, Angela
1995
16 3S1 p. 77S-
1 p.
artikel
114 P85 Considerations regarding “measurement visits” during follow up of clinical trials Paranandi, Lata
1995
16 3S1 p. 120S-121S
nvt p.
artikel
115 P57 Coordinating recruitment in the Women's Health Initiative Hunt, Julie R.
1995
16 3S1 p. 105S-
1 p.
artikel
116 P86 Cost analysis in clinical trials Wisniewski, Stephen R.
1995
16 3S1 p. 121S-
1 p.
artikel
117 P38 Data analysis plan development in a changing environment Capizzi, Thomas
1995
16 3S1 p. 93S-94S
nvt p.
artikel
118 P13 Data dictionary driven export of a relational data base to SAS data sets Paulsen, Jay M.
1995
16 3S1 p. 79S-80S
nvt p.
artikel
119 P04 Data management considerations for the HIVNET clinical trials Williams, Allan E.
1995
16 3S1 p. 74S-75S
nvt p.
artikel
120 P65 Data management issues in angiographic core laboratory data in coronary studies Kennard, Elizabeth D.
1995
16 3S1 p. 110S-
1 p.
artikel
121 P112 Decision tree analysis: Application in diagnosing hemodynamically severe carotid stenosis Reed III, J.F.
1995
16 3S1 p. 136S-
1 p.
artikel
122 P40 Design and analysis of clinical trials via sequential conditional probability ration test Ming, Tan
1995
16 3S1 p. 94S-95S
nvt p.
artikel
123 P67 Design and implementation of a computerized system for a colon cancer prevention program Lin, K.
1995
16 3S1 p. 111S-
1 p.
artikel
124 P68 Design and implementation of a patient tracking system for the Ontario trial of active compression-decompression cardiopulmonary resuscitation (OTAC) Campbell-Daigle, Fiona
1995
16 3S1 p. 111S-112S
nvt p.
artikel
125 P49 Designing standard reports for a clinical research database Marks, Linda D.
1995
16 3S1 p. 100S-101S
nvt p.
artikel
126 P98 Design of a phase III trial of cryptococcal meningitis in AIDS patients Cloud, Gretchen
1995
16 3S1 p. 128S-
1 p.
artikel
127 P84 Drop-outs and drop-ins in a clinical trial of a lipid-lowering agent Byington, Robert P.
1995
16 3S1 p. 120S-
1 p.
artikel
128 P45 Effects of rapid accrual on interim safety and efficacy monitoring: The minocycline in rheumatoid arthritis (MIRA) trial Fowler, Sarah
1995
16 3S1 p. 98S-
1 p.
artikel
129 P80 Electronic documentation for validation of statistical analysis programming for data from clinical trials Bell, Margie
1995
16 3S1 p. 117S-118S
nvt p.
artikel
130 P103 Establishing normative values of public health for outcomes based research Wasser, T.E.
1995
16 3S1 p. 131S-
1 p.
artikel
131 P117 Estimation of treatment effect and its resolution using a two-phase mixed model Wei, Lynn
1995
16 3S1 p. 138S-139S
nvt p.
artikel
132 P113 Evaluating interrater agreement based on categorical scales Kotey, Paul
1995
16 3S1 p. 136S-
1 p.
artikel
133 P01 Evaluating the benefits of patient video during the informed consent process Weston, J.
1995
16 3S1 p. 73S-
1 p.
artikel
134 P30 Experience with multivariate survival analysis for clinical trials Van Natta, Mark L.
1995
16 3S1 p. 89S-
1 p.
artikel
135 P32 Experience with preplanned meta analyses in linked clinical trials aimed at reducing frailty in older adults Schechtman, Kenneth B.
1995
16 3S1 p. 90S-
1 p.
artikel
136 P24 Factors in successful patient recruitment applying the six-box organizational model in a large VA cooperative study Collins, Dorothea
1995
16 3S1 p. 85S-86S
nvt p.
artikel
137 P97 Fast tracking with master contracts Brown, Philip M.
1995
16 3S1 p. 127S-
1 p.
artikel
138 P78 Forecasting enrollment capacity in a cooperative clinical trial network Shen, Wei
1995
16 3S1 p. 116S-117S
nvt p.
artikel
139 P41 Graphical display of three dimensional compositional data using a ternary diagram Nguyen, Ha H.
1995
16 3S1 p. 95S-
1 p.
artikel
140 P114 Graphical presentation of longitudinal data analyses: The nhlbi growth and health study (NGHS) Similo, Shari L.
1995
16 3S1 p. 137S-
1 p.
artikel
141 P44 Implementation of multicenter clinical trials: The Alzheimer's Disease Cooperative Study protocol implementation manual Schafer, Kimberly
1995
16 3S1 p. 97S-
1 p.
artikel
142 P91 Improved readability of consent forms for clinical trials Sadura, Anna
1995
16 3S1 p. 124S-
1 p.
artikel
143 P07 Information system for a multi-hospital study using optical scanning and hospital database downloads Anderson, Stephen
1995
16 3S1 p. 76S-
1 p.
artikel
144 P59 Informed consent vs. randomized consent: A randomized trial with healthy subjects Gallo, Ciro
1995
16 3S1 p. 106S-107S
nvt p.
artikel
145 P26 Initiating a clinical trial utilizing project management software: A pharmacy perspective Peterson, Jenine C.
1995
16 3S1 p. 86S-87S
nvt p.
artikel
146 P74 Insuring data completeness from multiple data sources Gross, Richard D.
1995
16 3S1 p. 114S-
1 p.
artikel
147 P17 Issues in using a university data coordinating center for an industry sponsored clinical trial Barnhart, Murray D.
1995
16 3S1 p. 81S-
1 p.
artikel
148 P33 Longitudinal analysis of binary data in the V.A. cooperative study of sulfasalazine for the treatment of seronegative spondyloarthropathies Reda, Domenic
1995
16 3S1 p. 90S-91S
nvt p.
artikel
149 P35 Longitudinal study of cardinal features of cognitive dysfunction in alzheimer's disease Talwalker, Sheela
1995
16 3S1 p. 92S-
1 p.
artikel
150 P105 Maintenance of adherence to a dietary intervention 9 months after completion of a clinical trial Kusek, John
1995
16 3S1 p. 132S-
1 p.
artikel
151 P102 Methods to promote staff retention in a large, multi-site chemoprevention study: The caret experience Powell, Corinne
1995
16 3S1 p. 130S-
1 p.
artikel
152 P71 Migration of statistical processing across operating systems Pollizzi, Susan
1995
16 3S1 p. 113S-
1 p.
artikel
153 P111 Missing data imputation for continuous outcome measures: The dietary intervention study in children (DISC) McMahon, Robert P.
1995
16 3S1 p. 135S-
1 p.
artikel
154 P14 Monitoring data error rates: A tool for maintaining high standards in data quality Lawlor, Sharon
1995
16 3S1 p. 80S-
1 p.
artikel
155 P54 Ninety-nine percent patient follow-up in a large clinical trial: A five step plan Davis, Catherine G.
1995
16 3S1 p. 103S-104S
nvt p.
artikel
156 P82 Objective classification of clinical events in large clinical trials: Is it worth the cost? Granger, Christopher
1995
16 3S1 p. 119S-
1 p.
artikel
157 P79 Outcome research in angina pectoris: Limitations of some phase III trials Ahn, Sylvie
1995
16 3S1 p. 117S-
1 p.
artikel
158 P60 Patient satisfaction with a dietary intervention: The modification of diet in renal disease study Olson, Marian
1995
16 3S1 p. 107S-
1 p.
artikel
159 P95 Planning for long-term storage and retrieval of clinical trial specimens: The postmenopausal estrogen/progestin intervention (PEPI) trial Wasilauskas, Carol H.
1995
16 3S1 p. 126S-
1 p.
artikel
160 P119 Protecting rights of patients, sites, investigators and sponsors while facilitating timely trial initiation Herr, Barbara
1995
16 3S1 p. 139S-140S
nvt p.
artikel
161 P21 Quality control in clinical trials: Protocol compliance auditing Templeton, M.A.
1995
16 3S1 p. 83S-84S
nvt p.
artikel
162 P104 Quality of life data collected before and after randomization Brooks, Maria Mori
1995
16 3S1 p. 131S-132S
nvt p.
artikel
163 P47 Randomized controlled trial of aerobic plus resistance exercise training in patients with congestive heart failure Teo, Koon
1995
16 3S1 p. 99S-
1 p.
artikel
164 P58 Recruitment success by type of site in the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) vanguard Egan, Debra A.
1995
16 3S1 p. 106S-
1 p.
artikel
165 P22 Reporting of treatment allocation methods and determinants of sample size in multicenter trials Cramer, Laura D.
1995
16 3S1 p. 84S-
1 p.
artikel
166 P28 Response criteria in solid tumours: UNI-dimensional vs BI-dimensional measurements Muldal, Alison
1995
16 3S1 p. 88S-
1 p.
artikel
167 P56 Retention plans in the Women's Health Initiative Bowen, Deborah
1995
16 3S1 p. 104S-105S
nvt p.
artikel
168 P27 Review of measurement, assessment, analysis and reporting of visual acuity in clinical trials in ophthalmology Kiri, Nandini
1995
16 3S1 p. 87S-
1 p.
artikel
169 P43 Rises in the CD4 cell count prior to anti-HIV treatment: Consequences for trial design? Weverling, Gerrit J.
1995
16 3S1 p. 96S-97S
nvt p.
artikel
170 P69 Role of Remote Database Management (RDM) as a quality assurance tool: The tone experience Lane, Kathy R.
1995
16 3S1 p. 112S-
1 p.
artikel
171 P66 SAS® macro routines for the monitoring and the analysis of studies requiring prolonged follow-up Tinazzi, A.
1995
16 3S1 p. 110S-111S
nvt p.
artikel
172 P39 Selection of appropriate controls for comparison of survival curves with time-dependent events Forman, Sandra
1995
16 3S1 p. 94S-
1 p.
artikel
173 P99 Selection of clinical sites for the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) Pressel, Sara
1995
16 3S1 p. 128S-129S
nvt p.
artikel
174 P18 Strang National High Risk Breast Registry (NHRR) database: Systems architecture and data normalization for long-term research Potter, Charles
1995
16 3S1 p. 82S-
1 p.
artikel
175 P51 Subject enrollment rates in multicenter drug trials: An examination of causes and effects Barnhill, Jamie G.
1995
16 3S1 p. 101S-102S
nvt p.
artikel
176 P75 Survey to evaluate case report forms for national multi-center clinical trials designed using genetic forms module Koski, Beverly
1995
16 3S1 p. 115S-
1 p.
artikel
177 P36 Tests useful in situations where treatments increase variability relative to controls Blair, R.Clifford
1995
16 3S1 p. 92S-93S
nvt p.
artikel
178 P53 The changing role of informed consent Brown, Philip M.
1995
16 3S1 p. 103S-
1 p.
artikel
179 P87 The cost of screening patients for a randomized clinical trial in orthodontics Philips, Ceib
1995
16 3S1 p. 122S-
1 p.
artikel
180 P109 The role of a Regional Resource Center in a large multicenter clinical study Margitić, Susan
1995
16 3S1 p. 134S-135S
nvt p.
artikel
181 P62 The role of the regional study coordinator in a multicenter clinical trial Balanoff, Diane
1995
16 3S1 p. 108S-
1 p.
artikel
182 P93 The value of pilot study data when designing randomized controlled trials for nonpharmacological interventions Wilkins, Annette
1995
16 3S1 p. 125S-
1 p.
artikel
183 P101 Time required for the protein intervention in the modification of diet in renal disease study Olson, Marian
1995
16 3S1 p. 129S-130S
nvt p.
artikel
184 P02 Touchtone technologies: Let your fingers do the talking Rushing, Scott
1995
16 3S1 p. 73S-74S
nvt p.
artikel
185 P52 Tracing research subjects lost to follow-up with the aid of a National Credit Bureau Vitek, Mary Ellen
1995
16 3S1 p. 102S-
1 p.
artikel
186 P20 (Un)predictability of monthly accrual in randomized clinical trials Coates, Townes C.
1995
16 3S1 p. 83S-
1 p.
artikel
187 P77 Use of edit-query tables as a data management tool in clinical trials Feak, Glen A.B.
1995
16 3S1 p. 116S-
1 p.
artikel
188 P89 Uses for large clinically accurate databases in clinical trial design Crosby, Ann
1995
16 3S1 p. 123S-
1 p.
artikel
189 P118 Using cumulative plots to detect biased assignments in unbalanced designs Helms, Laura E.
1995
16 3S1 p. 139S-
1 p.
artikel
190 P15 Using SAS© macros to automate data reports in multi-center clinical trials Thompson, Chris
1995
16 3S1 p. 80S-81S
nvt p.
artikel
191 P50 Validity, reliability, and responsiveness of subjective self-assessment of symptoms in asthma clinical trials Ih, Chang
1995
16 3S1 p. 101S-
1 p.
artikel
                             191 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland